GlassScriptPhysician profile
Sonal A Patel
NPI 1447456959
$2,172.61
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $341 · 2020: $419 · 2021: $736 · 2022: $597 · 2023: $15.77 · 2024: $64.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $80.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $80.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $391.56 | 2020-2021 | |
| Novo Nordisk INC | $299.25 | 2019-2022 | |
| Lilly USA, LLC | $209.61 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $168.85 | 2019-2022 | |
| Glaxosmithkline, LLC. | $162.19 | 2019-2022 | |
| Xeris Pharmaceuticals, INC. | $159.31 | 2021-2022 | |
| Pfizer INC. | $151.33 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $127.84 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $81.35 | 2019-2022 | |
| Allergan, INC. | $73.92 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.82 | 2022 | |
| Nestle Healthcare Nutrition INC. | $61.03 | 2021-2022 | |
| Abbott Laboratories | $47.71 | 2024 | Freestyle Libre 3 |
| Supernus Pharmaceuticals, INC. | $42.91 | 2019-2020 | |
| Abbvie INC. | $38.08 | 2021-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $32.50 | 2023-2024 | Dexcom G6 Transmitter |
| Ironwood Pharmaceuticals, INC | $29.86 | 2020 | |
| Almatica Pharma LLC | $16.73 | 2022 | |
| Medtronic Minimed, INC. | $13.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonal Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.